Connect
MJA
MJA

Psychotropic medication in pregnancy

Roisin N Worsley, Heather Gilbert and Jayashri Kulkarni
Med J Aust 2013; 199 (10): . || doi: 10.5694/mja13.10719
Published online: 18 November 2013

To the Editor: The report by O’Donnell and colleagues on the increasing rate of mental illness in parents of infants highlights a very important issue and is consistent with overseas studies that suggest there is increasing use of psychotropic medication in pregnancy.1,2


  • Monash Alfred Psychiatry Research Centre, Monash University, Melbourne, VIC.


Correspondence: roisin.worsley@monash.edu

Competing interests:

No relevant disclosures.

  • 1. O’Donnell M, Anderson D, Morgan VA, et al. Trends in pre-existing mental health disorders among parents of infants born in Western Australia from 1990 to 2005. Med J Aust 2013; 198: 485-488. <MJA full text>
  • 2. Epstein RA, Bobo WV, Shelton RC, et al. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf 2013; 22: 794-801.
  • 3. Kulkarni J, McCauley-Elsom K, Marston N, et al. Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy. Aust N Z J Psychiatry 2008; 42: 38-44.
  • 4. Miller LJ, Finnerty M. Sexuality, pregnancy and childrearing among women with schizophrenia-spectrum disorders. Psychiatr Serv 1996; 47: 502-506.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.